Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending June 14, 2015
Chemotherapy in Advanced Squamous NSCLC, Necitumumab as adjuvant to gemcitabine and cisplatin
Progression-free Survival in Stage III or IV Melanoma, With nivolumab alone, ipilimumab alone, or both together
BMI and Tumor Phenotype in CRC, High BMI reduces benefit of MSI-high tumors
Use of Estrogen by Postmenopausal Women, Does it affect incidence of colorectal cancer?
Dietary Patterns Following Prostate Cancer Diagnosis, Does diet affect mortality?
Must reads for theWeek ending June 7, 2015
RBC Transfusions in Sickle Cell Disease, Does cell age matter?
Prognoses in Metastatic Colorectal Cancer, Can primary tumor location predict survival?
LUMA as a Biomarker for Breast Cancer Risk, Body size and physical activity may play a role
Breast Cancer-Related Lymphedema, Is taxane-based chemotherapy causative?
Risks of Second Primary Cancers in BC Survivors, Exploring the roles of race and ethnicity
Must reads for theWeek ending May 31, 2015
Predicting Breast Cancer Survival, Brain metastases increase index’s significance
Inflammation and Breast Cancer, C-reactive protein may be prognostic
Off-label Therapy is Common in Breast Cancer, But, is it based on evidence?
Incidence of Lung Cancer in Chinese-Americans, Does immigration status matter?
Cancer Survivors’ Information Needs, What do they want to know, and when?
Must reads for theWeek ending May 24, 2015
FDA Approves Colorectal Cancer Test, Use approved for cobas KRAS mutation test
Predicting RCC Recurrence After Nephrectomy, What story do 16 genes tell?
Race and Ethnicity in Breast Cancer Survival, Tumor subtype is also a factor
Predicting Melanoma Survival, SNPs in Notch pathway genes may be key
BMI and Fitness in Breast Cancer, Do obesity and activity affect risk?
Must reads for theWeek ending May 17, 2015
Guideline: Radiotherapy in Locally Advanced NSCLC, ASTRO and ASCO release evidence-based recommendations
Revised International Pediatric Non-Hodgkin Lymphoma Staging System, Expert panel publishes evidence-based system
Intraperitoneal Chemotherapy in Advanced Ovarian Cancer, Are there long-term advantages?
Statins in Hormone-Sensitive Prostate Cancer, Does statin use affect time to progression?
Predicting CLL Prognosis, Can sequencing identify prognostic markers?